PIK3CA is implicated as an oncogene in ovarian cancer
Nature Genetics1999Vol. 21(1), pp. 99–102
Citations Over TimeTop 1% of 1999 papers
Laleh Shayesteh, Yiling Lu, Wen-Lin Kuo, R. A. Baldocchi, Tony E. Godfrey, Colin C. Collins, Daniel Pinkel, Bethan Powell, Gordon B. Mills, Joe W. Gray
Related Papers
- → Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice(2013)17 cited
- → Development and characterization of protein kinase B/AKT isoform-specific nanobodies(2020)10 cited
- → AKT2 is the Predominant Akt Isoform Expressed in Human Skeletal Muscle(2017)4 cited
- → Clinical value of isoform-specific detection and targeting of AKT1, AKT2 and AKT3 in breast cancer(2014)4 cited
- → Development and characterization of Protein Kinase B/AKT isoform-specific Nanobodies(2020)3 cited